Developer docs
API playgroundTry for free, no card

Search company profiles

Claritas Rx

Full company profile

uuid0003brn

Namestring
Claritas Rx
Legal namestring
Claritas Rx Inc.
Websiteurl
claritasrx.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

Claritas Rx is a US-based, privately held health technology company that provides a cloud-hosted SaaS platform — branded as the Claritas Rx Ascend® Platform — for pharmaceutical manufacturers operating in the specialty, rare disease, cell and gene therapy, and Buy & Bill segments. The platform aggregates and harmonizes patient-level data from specialty pharmacies, hubs, copay programs, specialty distributors, and other sources into a unified longitudinal patient record, then layers analytics, AI-powered risk prediction, omnichannel patient services CRM, consent management, and competitive benchmarking on top. Its core customer base is mid-to-large biopharma manufacturers seeking visibility into patient journeys across complex specialty distribution channels and improved first-fill, refill, and persistence rates.

The underlying technology is a modular, API-first SaaS architecture with HIPAA, GDPR, HITECH, SOC 2, and CCPA compliance built in. It comprises six integrated modules: Foundational Data Aggregation (the data layer), Access Analytics (real-time market access dashboards), Patient Watchtower™ (AI-driven care coordination), Patient Services Omnichannel CRM, Performance Benchmarking, and Consent Clearinghouse™. The company's proprietary AI/ML models claim 80-95% accuracy in predicting therapy discontinuation, prior authorization denials, and prescription abandonment, with a proprietary PHI-matching engine achieving 95%+ patient match accuracy across 5M+ patient-level data records.

Claritas Rx monetizes primarily through enterprise SaaS subscriptions priced per brand, indication, and data volume, with annual contracts and complementary professional services for implementation, data migration, and custom configuration. Distribution is exclusively direct enterprise sales, supported by inside sales and an event-driven marketing motion anchored in major biopharma industry conferences (Asembia, NASP, Hub East/West, Rare Disease Summit). The company reports a 94% customer retention rate and multiple named enterprise customers including Servier, Photocure ASA, and various mid-sized biopharma manufacturers. Founded in 2011 and headquartered in South San Francisco with an additional Philadelphia-area office, Claritas Rx has raised institutional capital from Kiplin Capital and Questa Capital Management.

Short descriptiontext

Claritas Rx provides a cloud-hosted SaaS platform that aggregates specialty pharmacy, hub, and copay data for biopharma manufacturers, using proprietary AI/ML models to predict therapy discontinuation and improve patient access, refill rates, and care coordination in specialty, rare disease, and cell and gene therapy markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSouth San Francisco, United States
HQ citystring
South San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty pharmacy analytics, biopharma patient journey, pharmaceutical data integration, market access analytics, patient services CRM
Industry2 codes
PRIMARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAO
DTx/SaMD Deployment, Integration & Reimbursement Enablement
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code2 codes
  • Software Publishers513210
  • Software Publishers5132
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Specialty Pharmacy Analytics Software
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1SaaS Platform Subscription
TypeSubscription Recurring
Description

Claritas Rx operates as a cloud-hosted SaaS platform with subscription-based pricing. The platform is sold as an integrated suite of solutions (Foundational Data Aggregation, Access Analytics, Patient Watchtower, Patient Services Omnichannel CRM, Performance Benchmarking) with modular components that can be bundled based on customer needs. Pricing varies by brand, indication, and data volume.

claritasrx.com
2Professional Services
TypeProfessional Services
Description

Implementation services, training, and custom configuration services to deploy the platform and integrate with client systems. Includes data migration, system integration, workflow configuration, and ongoing customer success support.

claritasrx.com
3Data Aggregation Services
TypeData Monetisation
Description

Foundational Data Aggregation services providing validated, clean, curated data across disparate data sources. This includes data processing, validation, normalization, de-identification, and ongoing data quality monitoring.

claritasrx.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise SaaS subscription with modular components
ModelSubscriptionBilling cadenceAnnual
Notes

Platform subscription with modular solution components (Foundational Data Aggregation, Access Analytics, Patient Watchtower, Omnichannel CRM, Performance Benchmarking). Pricing varies by brand count, therapeutic areas served, patient data volume, and number of data sources integrated. Annual contracts with volume-based pricing for larger portfolios.

claritasrx.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 6 records shown
1Claritas Rx Ascend® Platform
Description

The intelligent platform combining advanced analytics, real-world patient data, AI, and omnichannel CRM tools to help patients start and remain on therapy.

claritasrx.com
+5 more records
Core offering1 text field

Claritas Rx sells the Claritas Rx Ascend® Platform, a cloud-hosted SaaS suite that aggregates and harmonizes fragmented data from specialty pharmacies, hubs, copay programs, distributors, and EMR/claims vendors into a unified longitudinal patient record. The platform layers AI/ML predictive risk profiling, real-time market access dashboards, omnichannel patient services CRM, competitive benchmarking, and centralized consent management on top of that data foundation for biopharma manufacturers commercializing specialty, rare disease, cell & gene, and Buy & Bill therapies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 20% increase in first fill rates in complex cases
+7 more records
Product overview1 text field

Claritas Rx offers the Claritas Rx Ascend® Platform — a cloud-hosted SaaS platform that unifies real-world specialty pharmaceutical data with advanced analytics, AI, and intelligent case management. The platform operates as a platform-plus-modules architecture with six integrated components: Foundational Data Aggregation (the foundational data layer that aggregates, validates, and harmonizes data from specialty pharmacies, hubs, copay programs, distribution partners, and EMR/claims vendors into a unified longitudinal patient record), Access Analytics (real-time dashboards for market access KPIs across channel, payer, and patient metrics), Patient Watchtower™ (AI-powered care coordination and predictive risk scoring), Patient Services Omnichannel CRM (purpose-built CRM with omnichannel outreach and AI-driven next-best-action recommendations), Performance Benchmarking (competitive intelligence comparing brand KPIs against the industry), and Consent Clearinghouse™ (centralized consent management across all patient touchpoints). The platform achieves +95% patient match accuracy and drives measurable improvements including +20% fill rate increases in complex cases.

Product and service7 records
1Claritas Rx Ascend® Platform
CategoryPlatform
Description

The cloud-hosted SaaS platform that unifies real-world specialty pharmaceutical data with advanced analytics, AI, and intelligent case management, and powers all Claritas Rx modules including Foundational Data Aggregation, Access Analytics, Patient Watchtower, Patient Services Omnichannel CRM, Performance Benchmarking, and Consent Clearinghouse for biopharma manufacturers.

2Foundational Data Aggregation
CategoryData integration
Description

The foundational data layer that aggregates, validates, and harmonizes patient data from specialty pharmacies, hubs, copay programs, distribution partners, and EMR/claims vendors into a unified, compliant longitudinal patient record with 95%+ patient match accuracy, built for biopharma manufacturers commercializing specialty and rare disease therapies.

3Access Analytics
CategoryAnalytics
Description

Real-time market access dashboard solution delivering next-day visibility into brand performance across channel, payer, and patient metrics including enrollments, fill rates, prior authorization, and inventory tracking for biopharma market access and commercial operations teams.

4Patient Watchtower™
CategoryCare coordination
Description

AI-powered care coordination platform that combines patient journey analytics with predictive risk profiling and integrated case coordination, built specifically for specialty and rare disease patients so that no patient falls through the cracks.

5Patient Services Omnichannel CRM
CategoryPatient services CRM
Description

Purpose-built CRM for patient services teams that unifies case management, omnichannel communication (phone, email, portal, text, fax), and workflow automation across specialty pharmacies, hubs, field teams, and case managers, powered by AI for predictive risk detection and next-best-action recommendations.

6Performance Benchmarking
CategoryCompetitive intelligence
Description

Real-time competitive intelligence solution that enables specialty biopharma brands to compare KPIs — fill rates, abandonment, and time-to-fill — against custom market baskets, therapeutic areas, or the entire industry using direct license data and proprietary aggregated metadata.

7Consent Clearinghouse™
CategoryConsent management
Description

The industry's first dedicated solution for standardizing and centralizing patient consent across oncology, rare disease, and specialty biopharma, verifying, reconciling, and continuously monitoring patient consent across every connected data source and network partner to give manufacturers real-time visibility and a defensible compliance record.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierNotableTypeStrategic or Co-development PartnerAnnounced on2026-03-17
Description

Joint presentation at the Rare Disease Summit on turning limited rare disease data into powerful insights. Collaboration focuses on rare disease analytics, ethics, and access strategy for patients with limited data visibility.

2HealthVerity
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-10-20
Description

Strategic partnership announced October 2025 to unlock more actionable real-world insights for commercial, RWE (Real-World Evidence), and HEOR teams. HealthVerity, as the leader in real-world data technology and privacy-compliant data exchange, integrates with Claritas Rx's patient journey analytics to enhance data capabilities for biopharma customers.

claritasrx.com
Strategic tierNotableTypeStrategic or Co-development Partner
Description

Partnership spotlighted in Healthcare Digital for leveraging advanced analytics and predictive modeling in the rare disease market. The collaboration focuses on improving patient access and outcomes in rare disease treatments through data-driven solutions.

Strategic tierNotableTypeStrategic or Co-development Partner
Description

Strategic partnership with Photocure ASA as part of their Hexvix/Cysview bladder cancer detection product strategy. Includes partnership with Claritas and a licensing agreement with Asieris for Cevira with milestone payments tied to regulatory approval in China.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

IQVIA is the largest life sciences analytics and RWE company globally, offering patient journey, commercial, and real-world evidence solutions that overlap directly with Claritas Rx's specialty pharma analytics offering, but at much broader scope across clinical and commercial.

TypeDirect peer
Description

Veeva's life sciences CRM and patient services suite (Veeva Vault, Veeva CRM) directly serves biopharma commercial and patient services teams, overlapping with Claritas Rx's Omnichannel CRM and Patient Watchtower offerings for specialty pharma manufacturers.

3ZS Associates
TypeDirect peer
Description

ZS is a specialty pharma analytics and consulting firm with deep offerings in patient journey, market access, and AI-driven commercial analytics for biopharma — closely comparable to Claritas Rx's specialty focus and data-driven approach.

TypeDirect peer
Description

Komodo Health aggregates real-world patient data and provides patient journey analytics for biopharma, overlapping directly with Claritas Rx's Foundational Data Aggregation and Performance Benchmarking capabilities.

TypeBroad incumbent
Description

Salesforce Health Cloud and Life Sciences Cloud provide CRM and patient engagement infrastructure for biopharma; a broad incumbent that competes with Claritas Rx's Omnichannel CRM via ecosystem breadth rather than specialty depth.

TypeEmerging player
Description

Aktana provides AI-driven commercial strategy and next-best-action recommendations for life sciences sales and marketing teams, overlapping with Claritas Rx's recommendation engine and predictive patient engagement features.

TypeDirect peer
Description

OptimizeRx delivers market access, affordability, and provider engagement solutions for life sciences, comparable to Claritas Rx's Access Analytics and Patient Watchtower offerings around access barriers and therapy initiation.

TypeEmerging player
Description

ConcertAI provides real-world evidence and AI solutions for specialty oncology and biopharma, comparable to Claritas Rx's RWE and predictive analytics for specialty/rare disease manufacturers.

TypeEmerging player
Description

Definitive Healthcare offers commercial intelligence and analytics for healthcare and life sciences, with overlap to Claritas Rx's Performance Benchmarking and market access analytics products.

TypeEmerging player
Description

MedHOK (now part of CoverMyMeds/Hearst Health) provides specialty pharmacy and patient access workflow tools, with adjacent overlap to Claritas Rx's prior authorization, hub, and patient services workflows.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Claritas Rx

Specialty Pharmacy Analytics Softwareclaritasrx.com

Claritas Rx provides a cloud-hosted SaaS platform that aggregates specialty pharmacy, hub, and copay data for biopharma manufacturers, using proprietary AI/ML models to predict therapy discontinuation and improve patient access, refill rates, and care coordination in specialty, rare disease, and cell and gene therapy markets.

What Claritas Rx does

Claritas Rx is a US-based, privately held health technology company that provides a cloud-hosted SaaS platform — branded as the Claritas Rx Ascend® Platform — for pharmaceutical manufacturers operating in the specialty, rare disease, cell and gene therapy, and Buy & Bill segments. The platform aggregates and harmonizes patient-level data from specialty pharmacies, hubs, copay programs, specialty distributors, and other sources into a unified longitudinal patient record, then layers analytics, AI-powered risk prediction, omnichannel patient services CRM, consent management, and competitive benchmarking on top. Its core customer base is mid-to-large biopharma manufacturers seeking visibility into patient journeys across complex specialty distribution channels and improved first-fill, refill, and persistence rates.

The underlying technology is a modular, API-first SaaS architecture with HIPAA, GDPR, HITECH, SOC 2, and CCPA compliance built in. It comprises six integrated modules: Foundational Data Aggregation (the data layer), Access Analytics (real-time market access dashboards), Patient Watchtower™ (AI-driven care coordination), Patient Services Omnichannel CRM, Performance Benchmarking, and Consent Clearinghouse™. The company's proprietary AI/ML models claim 80-95% accuracy in predicting therapy discontinuation, prior authorization denials, and prescription abandonment, with a proprietary PHI-matching engine achieving 95%+ patient match accuracy across 5M+ patient-level data records.

Claritas Rx monetizes primarily through enterprise SaaS subscriptions priced per brand, indication, and data volume, with annual contracts and complementary professional services for implementation, data migration, and custom configuration. Distribution is exclusively direct enterprise sales, supported by inside sales and an event-driven marketing motion anchored in major biopharma industry conferences (Asembia, NASP, Hub East/West, Rare Disease Summit). The company reports a 94% customer retention rate and multiple named enterprise customers including Servier, Photocure ASA, and various mid-sized biopharma manufacturers. Founded in 2011 and headquartered in South San Francisco with an additional Philadelphia-area office, Claritas Rx has raised institutional capital from Kiplin Capital and Questa Capital Management.

Claritas Rx firmographics

Firmographics
Name
Claritas Rx
Legal name
Claritas Rx Inc.
Website
https://claritasrx.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
101–250 employees
Short description
Claritas Rx provides a cloud-hosted SaaS platform that aggregates specialty pharmacy, hub, and copay data for biopharma manufacturers, using proprietary AI/ML models to predict therapy discontinuation and improve patient access, refill rates, and care coordination in specialty, rare disease, and cell and gene therapy markets.
Ownership category
akta.pro rank

Claritas Rx industry classification

Industry
Product category
Specialty Pharmacy Analytics Software
NAICS
Software Publishers (513210), Software Publishers (5132)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLACANAM
DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAO
DTx/SaMD Deployment, Integration & Reimbursement Enablement
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Specialty pharmacy analytics
  • Biopharma patient journey
  • Pharmaceutical data integration
  • Market access analytics
  • Patient services CRM

Where Claritas Rx is headquartered

Location

Headquarters

HQ city
South San Francisco
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Claritas Rx business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS Platform Subscription: Claritas Rx operates as a cloud-hosted SaaS platform with subscription-based pricing. The platform is sold as an integrated suite of solutions (Foundational Data Aggregation, Access Analytics, Patient Watchtower, Patient Services Omnichannel CRM, Performance Benchmarking) with modular components that can be bundled based on customer needs. Pricing varies by brand, indication, and data volume.
  2. Professional Services: Implementation services, training, and custom configuration services to deploy the platform and integrate with client systems. Includes data migration, system integration, workflow configuration, and ongoing customer success support.
  3. Data Aggregation Services: Foundational Data Aggregation services providing validated, clean, curated data across disparate data sources. This includes data processing, validation, normalization, de-identification, and ongoing data quality monitoring.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise SaaS subscription with modular components

Go-to-market motion2 records

Distribution channels3 records

Marketing channels9 records

Claritas Rx product offering

Product offering

Core offering

Claritas Rx sells the Claritas Rx Ascend® Platform, a cloud-hosted SaaS suite that aggregates and harmonizes fragmented data from specialty pharmacies, hubs, copay programs, distributors, and EMR/claims vendors into a unified longitudinal patient record. The platform layers AI/ML predictive risk profiling, real-time market access dashboards, omnichannel patient services CRM, competitive benchmarking, and centralized consent management on top of that data foundation for biopharma manufacturers commercializing specialty, rare disease, cell & gene, and Buy & Bill therapies.

Product overview

Claritas Rx offers the Claritas Rx Ascend® Platform — a cloud-hosted SaaS platform that unifies real-world specialty pharmaceutical data with advanced analytics, AI, and intelligent case management. The platform operates as a platform-plus-modules architecture with six integrated components: Foundational Data Aggregation (the foundational data layer that aggregates, validates, and harmonizes data from specialty pharmacies, hubs, copay programs, distribution partners, and EMR/claims vendors into a unified longitudinal patient record), Access Analytics (real-time dashboards for market access KPIs across channel, payer, and patient metrics), Patient Watchtower™ (AI-powered care coordination and predictive risk scoring), Patient Services Omnichannel CRM (purpose-built CRM with omnichannel outreach and AI-driven next-best-action recommendations), Performance Benchmarking (competitive intelligence comparing brand KPIs against the industry), and Consent Clearinghouse™ (centralized consent management across all patient touchpoints). The platform achieves +95% patient match accuracy and drives measurable improvements including +20% fill rate increases in complex cases.

Differentiator

Problem solved

Functional benefit

Brands

  • Claritas Rx Ascend® Platform: The intelligent platform combining advanced analytics, real-world patient data, AI, and omnichannel CRM tools to help patients start and remain on therapy.
  • Patient Watchtower™
  • Consent Clearinghouse™
  • Foundational Data Aggregation
  • Access Analytics
  • Performance Benchmarking

Products and services

  • Claritas Rx Ascend® Platform The cloud-hosted SaaS platform that unifies real-world specialty pharmaceutical data with advanced analytics, AI, and intelligent case management, and powers all Claritas Rx modules including Foundational Data Aggregation, Access Analytics, Patient Watchtower, Patient Services Omnichannel CRM, Performance Benchmarking, and Consent Clearinghouse for biopharma manufacturers.
  • Foundational Data Aggregation The foundational data layer that aggregates, validates, and harmonizes patient data from specialty pharmacies, hubs, copay programs, distribution partners, and EMR/claims vendors into a unified, compliant longitudinal patient record with 95%+ patient match accuracy, built for biopharma manufacturers commercializing specialty and rare disease therapies.
  • Access Analytics Real-time market access dashboard solution delivering next-day visibility into brand performance across channel, payer, and patient metrics including enrollments, fill rates, prior authorization, and inventory tracking for biopharma market access and commercial operations teams.
  • Patient Watchtower™ AI-powered care coordination platform that combines patient journey analytics with predictive risk profiling and integrated case coordination, built specifically for specialty and rare disease patients so that no patient falls through the cracks.
  • Patient Services Omnichannel CRM Purpose-built CRM for patient services teams that unifies case management, omnichannel communication (phone, email, portal, text, fax), and workflow automation across specialty pharmacies, hubs, field teams, and case managers, powered by AI for predictive risk detection and next-best-action recommendations.
  • Performance Benchmarking Real-time competitive intelligence solution that enables specialty biopharma brands to compare KPIs — fill rates, abandonment, and time-to-fill — against custom market baskets, therapeutic areas, or the entire industry using direct license data and proprietary aggregated metadata.
  • Consent Clearinghouse™ The industry's first dedicated solution for standardizing and centralizing patient consent across oncology, rare disease, and specialty biopharma, verifying, reconciling, and continuously monitoring patient consent across every connected data source and network partner to give manufacturers real-time visibility and a defensible compliance record.

Quantifiable outcome

  • 20% increase in first fill rates in complex cases
  • +7 more outcomes

Companies that use Claritas Rx

Customer profile

Named customers7 records

Segments6 records

Ideal customer profiles4 records

Claritas Rx technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability5 records

Feature7 records

Claritas Rx partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered notable and core.

  • Chiesi GroupnotableStrategic or Co-development Partner · 17 March 2026Joint presentation at the Rare Disease Summit on turning limited rare disease data into powerful insights. Collaboration focuses on rare disease analytics, ethics, and access strategy for patients with limited data visibility.
  • HealthVeritycoreTechnology or Integration · 20 October 2025Strategic partnership announced October 2025 to unlock more actionable real-world insights for commercial, RWE (Real-World Evidence), and HEOR teams. HealthVerity, as the leader in real-world data technology and privacy-compliant data exchange, integrates with Claritas Rx's patient journey analytics to enhance data capabilities for biopharma customers.
  • ServiernotableStrategic or Co-development PartnerPartnership spotlighted in Healthcare Digital for leveraging advanced analytics and predictive modeling in the rare disease market. The collaboration focuses on improving patient access and outcomes in rare disease treatments through data-driven solutions.
  • Photocure ASAnotableStrategic or Co-development PartnerStrategic partnership with Photocure ASA as part of their Hexvix/Cysview bladder cancer detection product strategy. Includes partnership with Claritas and a licensing agreement with Asieris for Cevira with milestone payments tied to regulatory approval in China.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Claritas Rx competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: IQVIA is the largest life sciences analytics and RWE company globally, offering patient journey, commercial, and real-world evidence solutions that overlap directly with Claritas Rx's specialty pharma analytics offering, but at much broader scope across clinical and commercial.
  • Salesforce (Health Cloud / Life Sciences Cloud): Salesforce Health Cloud and Life Sciences Cloud provide CRM and patient engagement infrastructure for biopharma; a broad incumbent that competes with Claritas Rx's Omnichannel CRM via ecosystem breadth rather than specialty depth.

Direct peers

  • Veeva Systems: Veeva's life sciences CRM and patient services suite (Veeva Vault, Veeva CRM) directly serves biopharma commercial and patient services teams, overlapping with Claritas Rx's Omnichannel CRM and Patient Watchtower offerings for specialty pharma manufacturers.
  • ZS Associates: ZS is a specialty pharma analytics and consulting firm with deep offerings in patient journey, market access, and AI-driven commercial analytics for biopharma — closely comparable to Claritas Rx's specialty focus and data-driven approach.
  • Komodo Health: Komodo Health aggregates real-world patient data and provides patient journey analytics for biopharma, overlapping directly with Claritas Rx's Foundational Data Aggregation and Performance Benchmarking capabilities.
  • OptimizeRx: OptimizeRx delivers market access, affordability, and provider engagement solutions for life sciences, comparable to Claritas Rx's Access Analytics and Patient Watchtower offerings around access barriers and therapy initiation.

Emerging players

  • Aktana: Aktana provides AI-driven commercial strategy and next-best-action recommendations for life sciences sales and marketing teams, overlapping with Claritas Rx's recommendation engine and predictive patient engagement features.
  • ConcertAI: ConcertAI provides real-world evidence and AI solutions for specialty oncology and biopharma, comparable to Claritas Rx's RWE and predictive analytics for specialty/rare disease manufacturers.
  • Definitive Healthcare: Definitive Healthcare offers commercial intelligence and analytics for healthcare and life sciences, with overlap to Claritas Rx's Performance Benchmarking and market access analytics products.
  • MedHOK (Hearst Health / CoverMyMeds): MedHOK (now part of CoverMyMeds/Hearst Health) provides specialty pharmacy and patient access workflow tools, with adjacent overlap to Claritas Rx's prior authorization, hub, and patient services workflows.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Claritas Rx social profiles

Digital presence

Claritas Rx compliance and trust

Trust signal

Compliance5 records

Claritas Rx financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Claritas Rx leadership team

Management profile

Number of profiles

Profiles12 records

Claritas Rx funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Claritas Rx M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Claritas Rx

What does Claritas Rx do?

Claritas Rx sells the Claritas Rx Ascend® Platform, a cloud-hosted SaaS suite that aggregates and harmonizes fragmented data from specialty pharmacies, hubs, copay programs, distributors, and EMR/claims vendors into a unified longitudinal patient record. The platform layers AI/ML predictive risk profiling, real-time market access dashboards, omnichannel patient services CRM, competitive benchmarking, and centralized consent management on top of that data foundation for biopharma manufacturers commercializing specialty, rare disease, cell & gene, and Buy & Bill therapies.

Is Claritas Rx a public or private company?

Claritas Rx is a private company. It is classified as venture growth investor backed and is currently operating.

When was Claritas Rx founded?

Claritas Rx was founded in 2011. It employs 101 to 250 people.

Where is Claritas Rx based?

Claritas Rx is headquartered in South San Francisco, United States, in the North America region.

How does Claritas Rx make money?

Three revenue lines are on record. SaaS Platform Subscription is the primary driver. The others are professional Services and data Aggregation Services.

Who are Claritas Rx's main competitors?

Broad incumbents on record are IQVIA and Salesforce (Health Cloud / Life Sciences Cloud). Direct peers are Veeva Systems, ZS Associates, Komodo Health and OptimizeRx. Emerging players are Aktana, ConcertAI, Definitive Healthcare and MedHOK (Hearst Health / CoverMyMeds).

Does Claritas Rx have an API?

No public API is recorded for Claritas Rx.

What industry is Claritas Rx in?

Claritas Rx's product category is Specialty Pharmacy Analytics Software. Its primary akta.pro industry code is HLACANAM, DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms, with a secondary code of HLACANAO, DTx/SaMD Deployment, Integration & Reimbursement Enablement. Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageClaritas Rx Appoints Biopharma Commercial Leader Jonathan Witt to Board of DirectorsClaritas Rx appointed Jonathan Witt to its Board of Directors. Witt brings over 25 years of biopharma experience, including as Genentech's Senior Vice President of Business Operations, where he led a customer experience strategy that delivered $700 million in portfolio revenue in 2024. He will guide the company's growth and patient impact.FinancialContent Business PageRelay Network and Claritas Rx Announce Strategic Partnership to Advance Patient Engagement for Specialty and Rare Disease ProgramsRelay Network and Claritas Rx announced a strategic partnership to combine Claritas Rx's specialty pharmacy data with Relay Network's HIPAA-compliant mobile messaging platform. The collaboration aims to improve patient access, adherence, and onboarding for specialty and rare disease programs. The companies will discuss the partnership in a live webinar on October 14, 2026.Business Wire BlogRelay Network and Claritas Rx Announce Strategic Partnership to Advance Patient Engagement for Specialty and Rare Disease ProgramsRelay Network and Claritas Rx announced a strategic partnership to combine Claritas Rx's specialty pharmacy data with Relay Network's HIPAA-compliant messaging platform for patient engagement. The collaboration aims to improve patient access, adherence, and onboarding for specialty and rare disease programs. The companies will host a live webinar on October 14, 2026.MorningstarEverest Group Finds Patients in Rare and Specialty Markets Are Getting More Touches and Less HelpEverest Group released a white paper on omnichannel patient engagement, finding that programs adding channels without coordination increase outreach volume while reducing case advancement. The report highlights that data-first foundations, consent governance, and AI-assisted decisioning are needed to coordinate cross-entity support.FinancialContent Business PageClaritas Rx Wins Fierce AI Innovation Award for Omnichannel Engagement StrategyClaritas Rx won the Fierce AI Innovation Award in the Omnichannel Engagement Strategy category for its Patient Watchtower and Patient Services Omnichannel CRM. The AI-powered solutions predict therapy discontinuation up to 90 days in advance with up to 80% precision and coordinate outreach across partners. The company reports a 20% improvement in fill rates and a 98% partner response rate within 24 hours.MorningstarClaritas Rx Wins Fierce AI Innovation Award for Omnichannel Engagement StrategyClaritas Rx won the Fierce AI Innovation Award in the Omnichannel Engagement Strategy category for its Patient Watchtower and Patient Services Omnichannel CRM. The AI-powered solutions predict therapy discontinuation up to 90 days in advance with up to 80% precision and have delivered a 20% improvement in fill rates and a 17% increase in refill rates.BioXconomyPatient Services Need Actionable IntelligenceMeghna Misra, vice president of product at Claritas Rx, argues that the patient services industry suffers from an actionable intelligence problem rather than a data deficit, where siloed information and poor governance prevent proactive patient support. She highlights that AI initiatives often fail due to lack of workflow integration and fragmented consent infrastructure across stakeholders like specialty pharmacies and hubs.AijournClaritas Rx Named to the 2026 Inc. 5000 List for the Second Consecutive YearClaritas Rx has been named to the 2026 Inc. 5000 list for the second consecutive year, recognizing it as one of America’s fastest-growing private companies. This honor coincides with the company's 15th anniversary and underscores its continued partnership with biopharma clients in improving patient access to therapies.Business Wire BlogClaritas Rx Named to the 2026 Inc. 5000 List for the Second Consecutive YearClaritas Rx has been named to the 2026 Inc. 5000 list for the second consecutive year, recognizing it as one of America's fastest-growing private companies. This honor coincides with the company's 15th anniversary and underscores its continued role as a partner to biopharma clients in managing patient journeys.FinancialContent Business PageClaritas Rx Named to the 2026 Inc. 5000 List for the Second Consecutive YearClaritas Rx has been named to the 2026 Inc. 5000 list for the second consecutive year, recognizing it among America's fastest-growing private companies. This honor coincides with the company's 15th anniversary of partnering with life sciences clients to support patient access and therapy adherence. Claritas Rx emphasizes its commitment to client trust and its focus on improving patient journeys through innovative solutions.